Log In
Print
BCIQ
Print
Print this Print this
 

Fispemifene

  Manage Alerts
Collapse Summary General Information
Company Forendo Pharma Oy
DescriptionSelective estrogen receptor modulator (SERM)
Molecular Target Estrogen receptor (ESR1)
Mechanism of ActionSelective estrogen receptor modulator (SERM)
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$317.5M

$5.0M

$305.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today